• 1
    Gauderer MW, Ponsky JL, Izant RJ Jr. Gastrostomy without laparotomy: a percutaneous endoscopic technique. J Pediatr Surg 1980; 15: 8725.
  • 2
    Ahmad I, Mouncher A, Abdoolah A, et al. Antibiotic prophylaxis for percutaneous endoscopic gastrostomy – a prospective, randomised, double-blind trial. Aliment Pharmacol Ther 2003; 18: 20915.
  • 3
    Safadi BY, Marks JM, Ponsky JL. Percutaneous endoscopic gastrostomy: an update. Endoscopy 1998; 30: 7819.
  • 4
    Sharma VK, Howden CW. Meta-analysis of randomized, controlled trials of antibiotic prophylaxis before percutaneous endoscopic gastrostomy. Am J Gastroenterol 2000; 95: 31336.
    Direct Link:
  • 5
    Sharma VK, Howden CW. Antibiotic prophylaxis before percutaneous endoscopic gastrostomy prevents infection and is cost saving. Gastrointest Endosc 2000; 51: 3324.
  • 6
    Bramble MG. Antibiotic Prophylaxis in Gastrointestinal Endoscopy. London: British Society of Gastroenterology, 2001.
  • 7
    Hull M, Beane A, Bowen J, Settle C. Methicillin-resistant Staphylococcus aureus infection of percutaneous endoscopic gastrostomy sites. Aliment Pharmacol Ther 2001; 15: 18838.
  • 8
    Robins G, Hull M. Antibiotic prophylaxis for percutaneous endoscopic gastrostomy insertion in patients with non-malignant disease. Aliment Pharmacol Ther 2006; 23: 12767.
  • 9
    Saadeddin A, Freshwater DA, Fisher NC, Jones BJ. Antibiotic prophylaxis for percutaneous endoscopic gastrostomy for non-malignant conditions: a double-blind prospective randomized controlled trial. Aliment Pharmacol Ther 2005; 22: 56570.
  • 10
    Panigrahi H, Shreeve DR, Tan WC, Prudham R, Kaufman R. Role of antibiotic prophylaxis for wound infection in percutaneous endoscopic gastrostomy (PEG): result of a prospective double-blind randomized trial. J Hosp Infect 2002; 50: 3125.
  • 11
    Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary Control Clin Trials 1996; 17: 112.
  • 12
    Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses. Lancet 1999; 354: 1896900.
  • 13
    Bero L, Rennie D. The Cochrane Collaboration. Preparing, maintaining, and disseminating systematic reviews of the effects of health care. JAMA 1995; 274: 19358.
  • 14
    Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 71948.
  • 15
    Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985; 27: 33571.
  • 16
    Cochran WG. The combination of estimates from different experiments. Biometrics 1954; 10: 10129.
  • 17
    Higgins JPT, Thompson SG. Quantifying heterogeneity in meta-analysis. Stat Med 1998; 17: 84156.
  • 18
    Sackett DL, Straus SE, Richardson WS, Rosenberg W, Haynes RB. Evidence-based Medicine: How to Practice and Teach EBM, 2nd edn. Edinburgh: Churchill Livingstone, 2000: 1338.
  • 19
    Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. JAMA 1992; 268: 2408.
  • 20
    Akkersdijk WL, Van Bergeijk JD, Van Egmond T, et al. Percutaneous endoscopic gastrostomy (PEG): comparison of push and pull methods and evaluation of antibiotic prophylaxis. Endoscopy 1995; 27: 3136.
  • 21
    Dormann AJ, Wigginghaus B, Risius H, et al. Antibiotic prophylaxis in percutaneous endoscopic gastrostomy (PEG) – results from a prospective randomized multicenter trial. Z Gastroenterol 2000; 38: 22934.
  • 22
    Gossner L, Keymling J, Hahn EG, Ell C. Antibiotic prophylaxis in percutaneous endoscopic gastrostomy (PEG): a prospective randomized clinical trial. Endoscopy 1999; 31: 11924.
  • 23
    Jain NK, Larson DE, Schroeder KW, et al. Antibiotic prophylaxis for percutaneous endoscopic gastrostomy. A prospective, randomized, double-blind clinical trial. Ann Intern Med 1987; 107: 8248.
  • 24
    Jonas SK, Neimark S, Panwalker AP. Effect of antibiotic prophylaxis in percutaneous endoscopic gastrostomy. Am J Gastroenterol 1985; 80: 43841.
  • 25
    Preclik G, Grune S, Leser HG, et al. Prospective, randomised, double blind trial of prophylaxis with single dose of co-amoxiclav before percutaneous endoscopic gastrostomy. BMJ 1999; 319: 8814.
  • 26
    Sturgis TM, Yancy W, Cole JC, Proctor DD, Minhas BS, Marcuard SP. Antibiotic prophylaxis in percutaneous endoscopic gastrostomy. Am J Gastroenterol 1996; 91: 23014.
  • 27
    Dormann AJ, Wigginghaus B, Risius H, et al. A single dose of ceftriaxone administered 30 min before percutaneous endoscopic gastrostomy significantly reduces local and systemic infective complications. Am J Gastroenterol 1999; 94: 32204.
    Direct Link:
  • 28
    Wilson AP. Surveillance of wound infections. J Hosp Infect 1995; 29: 816.
  • 29
    Shapiro M, Munoz A, Tager IB, Schoenbaum SC, Polk BF. Risk factors for infection at the operative site after abdominal or vaginal hysterectomy. N Engl J Med 1982; 307: 16616.
  • 30
    Mahid S, Hornung C, Minor K, Turina M, Galandiuk S. Systematic reviews and meta-analysis for the surgeon scientist. Br J Surg 2006; 93: 131524.
  • 31
    Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000; 56: 45563.
  • 32
    Ho CS, Yeung EY. Percutaneous gastrostomy and transgastric jejunostomy. Am J Roentgenol 1992; 158: 2517.
  • 33
    Mainie I, Loughrey A, Watson J, Tham TC. Percutaneous endoscopic gastrostomy sites infected by methicillin-resistant Staphylococcus aureus: impact on outcome. J Clin Gastroenterol 2006; 40: 297300.
  • 34
    Taylor RW, Manganaro L, O’Brien J, Trottier SJ, Parkar N, Veremakis C. Impact of allogenic packed red blood cell transfusion on nosocomial infection rates in the critically ill patient. Crit Care Med 2002; 30: 224954.
  • 35
    Vincent JL, Baron JF, Reinhart K, et al. Anemia and blood transfusion in critically ill patients. JAMA 2002; 288: 1499507.
  • 36
    Barie PS, Eachempati SR. Surgical site infections. Surg Clin North Am 2005; 85: 11159.
  • 37
    Chaudhary KA, Smith OJ, Cuddy PG, Clarkston WK. PEG site infections: the emergence of methicillin resistant Staphylococcus aureus as a major pathogen. Am J Gastroenterol 2002; 97: 17136.
    Direct Link:
  • 38
    Adachi S, Oura G, Sawai M, et al. The prophylaxis of wound infection in pull-percutaneous endoscopic gastrostomy: correlation with methicillin resistant Staphylococcus aureus positive patients in the throat. Nippon Shokakibyo Gakkai Zasshi 2002; 99: 216.
  • 39
    Horiuchi A, Nakayama Y, Kajiyama M, Fujii H, Tanaka N. Nasopharyngeal decolonization of methicillin resistant Staphylococcus aureus can reduce PEG peristomal wound infection. Am J Gastroenterol 2006; 101: 2747.
    Direct Link: